[1]任永昊,王一川.吴茱萸碱调节音猬因子/家族锌指蛋白1通路对免疫球蛋白A肾病大鼠肾损伤的影响[J].陕西医学杂志,2025,54(10):1299-1304.[doi:DOI:10.3969/j.issn.1000-7377.2025.10.001]
 REN Yonghao,WANG Yichuan.Effect of evodiamine on renal damage in IgA nephropathy rats by modulating Shh/Gli1 pathway[J].,2025,54(10):1299-1304.[doi:DOI:10.3969/j.issn.1000-7377.2025.10.001]
点击复制

吴茱萸碱调节音猬因子/家族锌指蛋白1通路对免疫球蛋白A肾病大鼠肾损伤的影响

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年10期
页码:
1299-1304
栏目:
基础研究
出版日期:
2025-10-05

文章信息/Info

Title:
Effect of evodiamine on renal damage in IgA nephropathy rats by modulating Shh/Gli1 pathway
作者:
任永昊王一川
(山东中医药大学附属医院肾内二科,山东 济南 250014)
Author(s):
REN YonghaoWANG Yichuan
(Department of Nephrology,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250014,China)
关键词:
吴茱萸碱免疫球蛋白A肾病音猬因子Gli家族锌指蛋白1肾损伤作用机制
Keywords:
EvodiamineImmunoglobulin A nephropathySonic hedgehogGlioma-associated oncogene homolog 1Renal damageMechanism of action
分类号:
R 692
DOI:
DOI:10.3969/j.issn.1000-7377.2025.10.001
文献标志码:
A
摘要:
目的:探讨吴茱萸碱(Evo)调节音猬因子(Shh)/Gli家族锌指蛋白1(Gli1)通路对免疫球蛋白A肾病(IgAN)大鼠肾损伤的影响。方法:将SD大鼠随机分为NC组、IgAN组、L-Evo组(20 mg/kg Evo)、H-Evo组(40 mg/kg Evo)、H-Evo+PUR组(40 mg/kg Evo+5 mg/kg Shh激活剂Purmorphamine)。全自动生化分析仪测定各组尿液中24 h尿蛋白、尿红细胞及血清中血肌酐、血尿素氮、白蛋白水平。ELISA测定各组血清中肿瘤坏死因子α(TNF-α)、白细胞介素1β(IL-1β)水平,HE染色观察各组肾组织的病理学形态,免疫荧光染色观察各组肾组织中IgA、α-平滑肌肌动蛋白(α-SMA)表达水平,Western blot检测各组肾组织中Shh、Gli1及细胞外基质沉积相关蛋白表达。结果:与NC组比较,IgAN组尿液中24 h尿蛋白、尿红细胞及血清中血肌酐、血尿素氮、TNF-α、IL-1β水平上升,肾组织病理损伤严重,且肾组织中IgA、α-SMA、Shh、Gli1、纤连蛋白(Fibronectin)、胶原蛋白(Collagen)、层粘连蛋白(Laminin)水平上升,而血清中白蛋白水平下降(均P<0.05);与IgAN组比较,L-Evo组、H-Evo组尿液中24 h尿蛋白、尿红细胞及血清中血肌酐、血尿素氮、TNF-α、IL-1β水平下降,肾组织病理损伤减轻,且肾组织中IgA、α-SMA、Shh、Gli1、Fibronectin、Collagen、Laminin水平下降,而血清中白蛋白水平上升(均P<0.05);与H-Evo组比较,H-Evo+PUR组尿液中24 h尿蛋白、尿红细胞及血清中血肌酐、血尿素氮、TNF-α、IL-1β水平上升,肾组织病理损伤严重,且肾组织中IgA、α-SMA、Shh、Gli1、Fibronectin、Collagen、Laminin水平上升,而血清中白蛋白水平下降(均P<0.05)。结论:Evo可能通过抑制Shh/Gli1通路,抑制炎症反应,减少IgA、α-SMA的表达及细胞外基质的沉积,阻碍肾纤维化过程,改善肾组织的病理损伤。
Abstract:
Objective:To explore the effect of evodiamine (Evo) on renal damage in immunoglobulin A nephropathy (IgAN) rats by modulating sonic hedgehog (Shh)/Glioma-associated oncogene homolog 1 (Gli1) pathway.Methods:SD rats were stochastically assigned into NC group,IgAN group,L-Evo group (20 mg/kg Evo),H-Evo group (40 mg/kg Evo),and H-Evo+PUR group (40 mg/kg Evo+5 mg/kg Shh activator Purmorphoamine).Fully automated biochemical analyzer was used to measure urine 24-hour urine protein,urine red blood cells,and serum creatinine,blood urea nitrogen,and albumin in each group.ELISA was used to measure serum tumor necrosis factor α (TNF-α) and interleukin 1β(IL-1β) in each group,and HE staining was used to observe the pathological morphology of renal tissue in each group.Immunofluorescence staining was used to observe IgA and α-SMA in renal tissues of each group.Western blot was used to detect Shh,Gli1,and extracellular matrix deposition related proteins in kidney tissues of each group.Results:For the NC group,the IgAN group showed an increase in 24-hour urine protein,urine red blood cells,and serum creatinine,blood urea nitrogen,TNF-α,and IL-1β,severe renal tissue pathological damage,an increase in IgA,α-SMA,Shh,Gli1,Fibronectin,Collagen,and Laminin in renal tissue,and a decrease in serum albumin (all P<0.05).For the IgAN group,the L-Evo group and H-Evo group showed a decrease in 24-hour urine protein,urine red blood cells,and serum creatinine,blood urea nitrogen,TNF-α,and IL-1β,reduced renal tissue pathological damage,a reduction in IgA,α-SMA,Shh,Gli1,Fibronectin,Collagen,and Laminin in renal tissue,and a raise in serum albumin (all P<0.05).For the H-Evo group,the H-Evo+PUR group showed an increase in 24-hour urine protein,urine red blood cells,and serum creatinine,blood urea nitrogen,TNF-α,and IL-1β,severe renal tissue pathological damage,an increase in IgA,α-SMA,Shh,Gli1,Fibronectin,Collagen,and Laminin in renal tissue,and a decrease in serum albumin (all P<0.05).Conclusion:Evo may inhibit Shh/Gli1 pathway,suppress inflammatory responses,reduce IgA,α-SMA,and extracellular matrix deposition,hinder the process of renal fibrosis,and improve pathological damage to renal tissue.

参考文献/References:

[1]赵雪千,王雯瑾,张楠辉,等.IgA肾病患者补体血清水平及其系膜沉积强度与肾病理损伤程度的相关性[J].陕西医学杂志,2025,54(4):555-559.
[2]SUN Q,XIE L,SONG J,et al.Evodiamine:A review of its pharmacology,toxicity,pharmacokinetics and preparation researches[J].J Ethnopharmacol,2020,262:113164.
[3]YE C,ZHANG N,ZHAO Q,et al.Evodiamine alleviates lipopolysaccharide-induced pulmonary inflammation and fibrosis by activating apelin pathway[J].Phytother Res,2021,35(6):3406-3417.
[4]YU Y,HUANG X,LIANG C,et al.Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer[J].Eur J Pharmacol,2023,957:176007.
[5]PENG F,WU L,WU J,et al.Serum levels of sonic hedgehog in patients with IgA nephropathy are closely associated with intrarenal arteriolar lesions[J].Clin Biochem,2024,123(1):110-121.
[6]LUO Y,JIANG J,CHENG J,et al.Inhibitory effects of rhein on renal interstitial fibrosis via the SHH-Gli1 signal pathway[J].Evid Based Complement Alternat Med,2022,20(4):43-55.
[7]LI J J,LI L,LI S,et al.Sinomenine hydrochloride protects IgA nephropathy through regulating cell growth and apoptosis of T and B lymphocytes[J].Drug Des Devel Ther,2024,18(4):1247-1262.
[8]LI Y,LI W,JIANG H.Vitamin D and hydroxychloroquine reduce renal injury and Ki67 expression in a rat model of IgA nephropathy via TLR4[J].Chin Med J (Engl),2021,134(23):2896-2898.
[9]史慧远,宋纯东,宋珂,等.基于NIK/IKKα/p52通路探讨雷公藤多苷对IgA肾病大鼠的肾脏保护作用机制[J].中医学报,2024,39(8):1754-1760.
[10]PEREGUD D I,SHIROBOKOVA N I,KVICHANSKY A A,et al.Purmorphamine alters anxiety-like behavior and expression of hedgehog cascade components in rat brain after alcohol withdrawal[J].Biochemistry (Mosc),2024,89(11):1938-1949.
[11]SCIONTI K,MOLYNEUX K,SELVASKANDAN H,et al.New insights into the pathogenesis and treatment strategies in IgA nephropathy[J].Glomerular Dis,2021,2(1):15-29.
[12]ROBERTS L E,WILLIAMS C E C,ONI L,et al.IgA nephropathy:Emerging mechanisms of disease[J].Indian J Nephrol,2024,34(4):297-309.
[13]NORREGAARD R,MUTSAERS H A M,FROKI R J,et al.Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis[J].Physiol Rev,2023,103(4):2827-2872.
[14]HADPECH S,THONGBOONKERD V.Epithelial-mesenchymal plasticity in kidney fibrosis[J].Genesis,2024,62(1):e23529.
[15]LI L,FU H,LIU Y.The fibrogenic niche in kidney fibrosis:Components and mechanisms[J].Nat Rev Nephrol,2022,18(9):545-557.
[16]ERASLAN E,TANYELI A,POLAT E,et al.Evodiamine alleviates kidney ischemia reperfusion injury in rats:A biochemical and histopathological study[J].J Cell Biochem,2020,120(10):17159-17166.
[17]邹鑫,于冰,徐龙辉,等.吴茱萸碱调节SphK1/S1P信号通路对慢性肾衰竭大鼠肾纤维化的影响[J].广州中医药大学学报,2024,41(6):1560-1566.
[18]LU X,ZHANG W,LIU Y,et al.Evodiamine exerts inhibitory roles in nonsmall cell lung cancer cell A549 and its subpopulation of stemlike cells[J].Exp Ther Med,2022,24(6):74-86.
[19]张锦华,高明,朱小静,等.促红细胞生成素对高糖诱导大鼠近端肾小管上皮细胞转分化的影响[J].陕西医学杂志,2022,51(10):1183-1186,1200.
[20]ZENG J,BAO X.Tanshinone ⅡA attenuates high glucose-induced epithelial-to-mesenchymal transition in HK-2 cells through VDR/Wnt/β-catenin signaling pathway[J].Folia Histochem Cytobiol,2021,59(4):259-270.
[21]SIGAFOOS A N,PARADISE B D,FERNANDEZ-ZAPICO M E.Hedgehog/GLI signaling pathway:Transduction,regulation,and implications for disease[J].Cancers (Basel),2021,13(14):34-45.
[22]WANG C,LAI Z,TAN H,et al.Impaired cardiomyocytes accelerate cardiac hypertrophy and fibrosis by delivering exosomes containing Shh/N-Shh/Gli1 in angiotensin Ⅱ infused mice[J].Heliyon,2024,10(20):39332.
[23]WANG D,YIN L,CHEN R,et al.Senescent renal tubular epithelial cells activate fibroblasts by secreting Shh to promote the progression of diabetic kidney disease[J].Front Med (Lausanne),2023,9(4):101-120.
[24]LI Y,TU H,LUO Y,et al.Shen-shuai-ling formulation attenuates renal interstitial fibrosis in chronic kidney disease by regulating SHH-Gli1 signaling pathway[J].Evid Based Complement Alternat Med,2022,20(2):37-45.
[25]LUO Y,JIANG J,CHENG J,et al.Inhibitory effects of rhein on renal interstitial fibrosis via the SHH-Gli1 signal pathway[J].Evid Based Complement Alternat Med,2022,20(5):4398-4409.

备注/Memo

备注/Memo:
国家自然科学基金资助项目(82204881)
更新日期/Last Update: 2025-10-09